Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry.

Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, Ide H, Doi Y, Hirakawa Y, Nakamura U, Kitazono T.

Diabetes Care. 2013 Mar;36(3):611-7. doi: 10.2337/dc12-0904. Epub 2012 Nov 12.

2.

U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry.

Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Jodai T, Hirakawa Y, Nakamura U, Kitazono T.

Metabolism. 2014 Apr;63(4):484-91. doi: 10.1016/j.metabol.2013.12.001. Epub 2013 Dec 7.

PMID:
24411997
3.

Impact of night sleep duration on glycemic and triglyceride levels in Chinese with different glycemic status.

Zheng Y, Wang A, Pan C, Lu J, Dou J, Lu Z, Ba J, Wang B, Mu Y.

J Diabetes. 2015 Jan;7(1):24-30. doi: 10.1111/1753-0407.12186. Epub 2014 Nov 11.

PMID:
24981368
4.
5.

Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry.

Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Jodai T, Hirakawa Y, Nakamura U, Kitazono T.

PLoS One. 2013 Nov 12;8(11):e78968. doi: 10.1371/journal.pone.0078968. eCollection 2013.

6.

Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes.

El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2003 Jan 13;163(1):69-75.

PMID:
12523919
7.

Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?

Kuenen JC, Borg R, Kuik DJ, Zheng H, Schoenfeld D, Diamant M, Nathan DM, Heine RJ; ADAG Study Group.

Diabetes Care. 2011 Aug;34(8):1843-7. doi: 10.2337/dc10-2217. Epub 2011 Jun 23.

8.

Sleep architecture and glucose and insulin homeostasis in obese adolescents.

Koren D, Levitt Katz LE, Brar PC, Gallagher PR, Berkowitz RI, Brooks LJ.

Diabetes Care. 2011 Nov;34(11):2442-7. doi: 10.2337/dc11-1093. Epub 2011 Sep 20.

9.

Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.

Fu C, Ji L, Wang W, Luan R, Chen W, Zhan S, Xu B.

J Endocrinol Invest. 2012 Mar;35(3):269-73. doi: 10.3275/7743. Epub 2011 May 23.

PMID:
21606668
10.

Sleep duration and glycemic control in patients with diabetes mellitus: Korea National Health and Nutrition Examination Survey 2007-2010.

Kim BK, Kim BS, An SY, Lee MS, Choi YJ, Han SJ, Chung YS, Lee KW, Kim DJ.

J Korean Med Sci. 2013 Sep;28(9):1334-9. doi: 10.3346/jkms.2013.28.9.1334. Epub 2013 Aug 28.

11.

Comorbidity and glycemic control in patients with type 2 diabetes.

El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2001 May 28;161(10):1295-300.

PMID:
11371257
12.

Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study.

Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, Ide H, Doi Y, Hirakawa Y, Mukai N, Ninomiya T, Uchida K, Nakamura U, Sasaki S, Kiyohara Y, Kitazono T.

Diabetologia. 2013 Jan;56(1):70-7. doi: 10.1007/s00125-012-2746-3. Epub 2012 Oct 13.

PMID:
23064292
13.

Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.

PMID:
15955469
14.

Association between sleep duration and haemoglobin A1c in young adults.

Hancox RJ, Landhuis CE.

J Epidemiol Community Health. 2012 Oct;66(10):957-61. doi: 10.1136/jech-2011-200217. Epub 2011 Nov 7.

PMID:
22068028
15.

Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV; Northern California Kaiser Permanente Diabetes Registry.

Diabetes Care. 2001 Jul;24(7):1144-50.

PMID:
11423493
16.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III).

Diabetes Care. 2001 Jun;24(6):979-82.

PMID:
11375356
17.

Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study.

de Rekeneire N, Rooks RN, Simonsick EM, Shorr RI, Kuller LH, Schwartz AV, Harris TB; Health, Aging and Body Composition Study.

Diabetes Care. 2003 Jul;26(7):1986-92. Erratum in: Diabetes Care. 2003 Dec;26(12):3368.

PMID:
12832300
18.

Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

Diabet Med. 2008 Feb;25(2):174-8. doi: 10.1111/j.1464-5491.2007.02379.x.

PMID:
18290858
19.

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

Clin Ther. 2003 Apr;25(4):1074-95.

PMID:
12809958
20.

Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.

Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S.

BMJ. 2012 Feb 27;344:e486. doi: 10.1136/bmj.e486.

PMID:
22371867

Supplemental Content

Support Center